⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Troy BeaucoudrayM.D.

Neurology · Metairie, LA 70002

NPI: 1316105182

Share:𝕏fin

44

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers95th percentile opioid prescribingHigh fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

12,535

Total Claims

$1.1M

Drug Cost

572

Beneficiaries

$1,867

Cost/Patient

Risk Score Breakdown 44/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+10
High fills per patient+3

Score components are additive. Read full methodology

Peer Comparison vs. 13,194 Neurology providers

+3751%

Opioid rate vs peers

50.4% vs 1.3% avg

-54%

Cost per patient vs peers

$1,867 vs $4,034 avg

-25%

Brand preference vs peers

7.1% vs 9.4% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

Opioid Prescribing

50.4%

Opioid Rate

6,313

Opioid Claims

$777K

Opioid Cost

21.1%

Long-Acting Rate

This provider's opioid prescribing rate of 50.4% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

93% generic

Brand: 885 claims · $774K

Generic: 11,650 claims · $294K

Patient Profile

62

Avg Age

52%

Female

1.36

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About